The Nifty Pharma index was trading 0.69 per cent down at 13231.95.

Needle-free ZyCoV-D, manufactured by Ahmedabad-based Zydus Cadila, is the first Covid-19 vaccine approved for the 12 to 18 years age group ...

The country's health authorities had given emergency approval in August for Cadila's vaccine, the world's first COVID-19 DNA shot, in adult...

As per the report by the USFDA, Zydus Pharmaceuticals (USA) Inc, is recalling 2,880 bottles of Carvedilol tablets, USP 25 mg in the US due ...

The index was trading 2.13 per cent up at 13538.65.

The Nifty Pharma index was trading 0.32 per cent up at 11618.2.

The Nifty Pharma index was trading 1.03 per cent up at 8,202 around 12:30 pm.

The Nifty Pharma index was trading 2.61 per cent up at 8,514 around 01:30 pm.

Among other listed stocks out of the five, Cadila Healthcare gained 2.87 per cent at Rs 512 at around the same time.

RBI held repo rate at a six-year low of 6.25 per cent on April 6, 2017 and reverse repo rate by 0.25 per cent to 6 per cent.

Disease prevention is key to public health in both developing and the developed world and vaccines have the potential to improve the qualit...

The letter of December 23 stated examples of data deletions at the Moraiya and the unit’s failure to “adequately control the use of compute...

Founder of Ahmedabad-based Cadila Pharmaceuticals, Indravadan Modi, better known as the octogenarian horse-riding chairman, passed away at ...

Zydus Cadila concludes agreement with Canadian biotech company Microbix Biosystems to re-launch KINLYTIC, a life saving drug in North Ameri...

Drug maker Zydus Cadila on Friday announced its foray into Spain, the fifth largest pharmaceutical market in the world.

US-based Abbott Laboratories seeks to stop the Indian company, Zydus Cadila, from selling generic version of its drug, Depakote, in the US.

Ranbaxy Laboratories and Cadila Healthcare have received approval from the USFDA for Carvedilol tablets in the strengths - 3.125 mg, 6.25 m...